Umbilical Cord Tissue-derived Mesenchymal Stem Cells Should be Considered as Adjuvant Therapy for COVID-19 Treatment: An Opinion from Pooled Clinical Evidence. Biomed. Res. Ther. 2021;8(9):4583-4595. doi:10.15419/bmrat.v8i9.694